
亚太地区心电图遥测设备市场预测至 2028 年 - COVID-19 影响和按产品划分的区域分析(静息心电图设备、压力心电图设备等);最终用户(家庭医疗保健和医院)
No. of Pages: 111 | Report Code: TIPRE00022984 | Category: Life Sciences
No. of Pages: 111 | Report Code: TIPRE00022984 | Category: Life Sciences
心电图设备监测并记录心脏的电活动,该设备检测并拾取极化和电脉冲产生的电脉冲。心脏组织去极化并将其转化为波形。这有助于医生或心脏病专家诊断心脏异常以及心室的大小和位置。
因此,预计老年人口的激增将在未来几年对心电图遥测设备产生巨大的需求。预计将进一步推动心电图遥测设备市场的发展。
已经采取了许多措施来遏制 COVID-19 的传播,这给包括医疗保健行业在内的许多公司造成了严重的运营中断。员工隔离、供应链故障和需求减少给企业带来了严重的麻烦。此外,私立连锁医院的住院和门诊量也大幅下降。为了缓解医疗保健系统的压力,许多诊所已经推迟了非危重的心脏手术。根据英国外科杂志 5 月 12 日发表的报告,印度每周取消的手术数量估计为 48,728 例。此外,医疗器械公司开始预测,由于人们呆在家里,中国市场的销售额将大幅下降。飞利浦、GE Healthcare 和 Hill Rom 等许多大型医疗器械公司都预测在中国的销售额将下降。 2月份中国几乎没有进行择期手术。此类活动预计将对亚太地区心电图遥测设备市场产生负面影响。
亚太地区心电图遥测设备市场预计将从2021年的2.454亿美元增长到2028年的3.992亿美元;预计 2021 年至 2028 年复合年增长率为 7.2%。由于人们生活方式的转变,以及现代化技术的引入,其他与 CVD 相关的健康指征增加,CVD 的发病率在发达国家急剧增加。设施。先进和现代化的基础设施以及不断变化的工作模式正在导致大众久坐的生活方式,同时压力水平也不断上升。例如,根据世界心脏联合会的统计,CVD 每年占所有死亡人数的 30%,即约 1730 万人死亡。城市化导致心血管疾病患病率不断增加——加上更多的污染和压力、高胆固醇和高热量食物的消耗、体育锻炼程度的减少,以及长QT综合征和儿茶酚胺能多形性室性心动过速等遗传问题——引发了对用于诊断的心脏监测产品的需求。因此,心电图遥测设备市场参与者正在利用发展中国家提供的机会,以具有成本效益的产品进入市场,这将推动其在预测期内的增长。
< p>
就产品而言,静息心电图设备细分市场在亚太地区心电图遥测设备市场中占据最大份额。 2020年。从最终用户来看,2020年医院细分市场在心电遥测设备市场中占有较大的市场份额。
准备本心电图遥测设备市场报告时参考的一些主要一手和二手来源亚太地区包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有 Cardiac Science Corporation
按产品
最终用户 最终用户 span> < span>按国家/地区
< strong>提及的公司
Strategic insights for Asia Pacific ECG Telemetry Device involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 245.4 Million |
Market Size by 2028 | US$ 399.2 Million |
Global CAGR (2021 - 2028) | 7.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific ECG Telemetry Device refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific ECG Telemetry Device Market is valued at US$ 245.4 Million in 2021, it is projected to reach US$ 399.2 Million by 2028.
As per our report Asia Pacific ECG Telemetry Device Market, the market size is valued at US$ 245.4 Million in 2021, projecting it to reach US$ 399.2 Million by 2028. This translates to a CAGR of approximately 7.2% during the forecast period.
The Asia Pacific ECG Telemetry Device Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific ECG Telemetry Device Market report:
The Asia Pacific ECG Telemetry Device Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific ECG Telemetry Device Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific ECG Telemetry Device Market value chain can benefit from the information contained in a comprehensive market report.